HBS Healthcare Event: The Future of Immuno-Oncology - Combination Treatments

Date and Time
Tuesday, November 14, 2017
6:00pm— 8:00pm
Add to calendar

The Wharton Health Care Management Alumni Association is pleased to share the following invitation from The HBS Healthcare Alumni Association  

The Future of Immuno-Oncology: Combination Treatments

Tuesday, November 14, 2017

Immuno-oncology treatments have provided renewed hope to cancer patients. Combination treatments bring the promise of increased efficacy with manageable side effects. Come hear from experts about what the future may bring.

Norman Selby, Board of Trustees at Memorial Sloan Kettering, Executive Chairman of RealEndpoints and PAIGE.AI, former Senior Partner at McKinsey

  • Sophie Opdyke, VP, Immuno-Oncology Lead, Global Commercial Development at Pfizer
  • Umer Raffat, Managing Director at Evercore ISI
  • Peter Bach, Director, Center for Health Policy and Outcomes at MSK
There will be opportunity to network with fellow alumni during this event. Light refreshments will be provided.

When: 6:00pm - 8:00pm, Tuesday November 14th
Where: UJA Conference Center, 130 East 59th Street, Room 712, New York, NY 10022

Please click here for more information and to register